2025 Annual Meeting | S9 - Autonomic Disorders
Program Materials Program Evaluations
| 11:15 AM - 11:27 AM PDT | Abstract |
001 - NET-Inhibition with Ampreloxetine, Blood Pressure, and Catecholamines in Patients with Neurogenic Orthostatic Hypotension
Valeria Iodice |
| 11:27 AM - 11:39 AM PDT | Abstract |
002 - The Impact of Ampreloxetine on Supine Hypertension: An Ambulatory Blood Pressure Monitoring Study.
Lucy Norcliffe-Kaufmann, PhD |
| 11:39 AM - 11:51 AM PDT | Abstract |
003 - Autonomic Impairment and Risk of Mortality in Early-Onset Parkinson Disease
Capucine Piat, MD |
| 11:51 AM - 12:03 PM PDT | Abstract |
004 - Elongator Protein 1 as a Biomarker of Disease Severity in Familial Dysautonomia
Maria Alejandra Gonzalez Duarte, MD, FAAN |
| 12:03 PM - 12:15 PM PDT | Abstract |
005 - Efficacy of Pharmacological Interventions for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP): A Systematic Review and Network Meta-Analysis
Vinay Suresh, MBBS |
| Dongin Sinn, MD | The institution of Dr. Sinn has received research support from Theravance BioPharma. The institution of Dr. Sinn has received research support from Dysautonomia International. |
| Melissa M. Cortez, DO | The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |
| Lucy Norcliffe-Kaufmann, PhD | Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of Theravance BioPharma. Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of 23andMe. |
| Alessandra Fanciulli, MD, PhD | Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Healthware. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Stopp-HSP. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otto Loewi Society. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial . Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Alessandra Fanciulli, MD, PhD has received research support from Parkinson Fond. The institution of Alessandra Fanciulli, MD, PhD has received research support from Tuba Foundation. The institution of Alessandra Fanciulli, MD, PhD has received research support from MSA Coalition. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Exchange Programme. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Science Fund. Alessandra Fanciulli, MD, PhD has received publishing royalties from a publication relating to health care. |
| Tadhg Guerin, MSc | Mr. Guerin has received personal compensation for serving as an employee of Theravance Biopharma. |
| Ross Vickery | Ross Vickery has nothing to disclose. |
| Horacio C. Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parexel. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care. |
| Italo Biaggioni, MD | Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theravance biopharma. Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance biopharma. The institution of Dr. Biaggioni has received research support from Theravance biopharma. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. |
| Valeria Iodice | The institution of Valeria Iodice has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance . The institution of Valeria Iodice has received research support from ACT, UCL. |
| Meredith A. Bryarly, MD | The institution of Dr. Bryarly has received research support from Theravance. |
| Aidan Mullan | Aidan Mullan has nothing to disclose. |
| Eduardo E. Benarroch, MD, FAAN | Dr. Benarroch has nothing to disclose. |
| Jeremy K. Cutsforth-Gregory, MD, FAAN | Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care. |
| Emanuele Camerucci, MD | Dr. Camerucci has nothing to disclose. |
| Khaled Ghoniem, MD | Dr. Ghoniem has nothing to disclose. |
| Pierpaolo Turcano, MD | Dr. Turcano has nothing to disclose. |
| Capucine Piat, MD | Dr. Piat has nothing to disclose. |
| Rodolfo Savica, MD, PhD, FAAN | The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc. |
| Muneeb Ahmad Muneer | Mr. Muneer has nothing to disclose. |
| Poorvikha S | Poorvikha S has nothing to disclose. |
| Adeeb Ali Mohammad, MBBS | Dr. Mohammad has nothing to disclose. |
| Archit Garg | Mr. Garg has nothing to disclose. |
| Arkansh Sharma | Mr. Sharma has nothing to disclose. |
| Vinay Suresh, MBBS | Dr. Suresh has nothing to disclose. |
| Vibhor Agrawal, MBBS | Dr. Agrawal has nothing to disclose. |
| Varsha Srinivasan | Ms. Srinivasan has nothing to disclose. |
| Ishita Lanjewar, MBBS | Dr. Lanjewar has nothing to disclose. |
| Kshitij Sonawale, MBBS | Dr. Sonawale has nothing to disclose. |
| Kaia L. Dalamo, NP | Dr. Dalamo has nothing to disclose. |
| Maria Alejandra Gonzalez Duarte, MD, FAAN | Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer. |
| Joel Gutierrez, MD | Dr. Gutierrez has nothing to disclose. |
| Maria Cotrina, PhD | Mrs. Cotrina has nothing to disclose. |